Synonyms that are in the dictionary are marked in green. Synonyms that are not in the dictionary are marked in red.
Antonyms that are in the dictionary are marked in green. Antonyms that are not in the dictionary are marked in red.
Cabaletta Bio currently has a consensus target price of $23.90, suggesting a potential upside of 86.72%. iTeos Therapeutics has a consensus target price of $36.33, suggesting a potential upside of 308.24%.
Finally, Bank of New York Mellon Corp raised its holdings in shares of Cabaletta Bio by 120.2% during the first quarter.